Thr239

Javascript is not enabled on this browser. This site will not work properly without Javascript.

Home > Phosphorylation Site Page: > Thr239 - ICF45 (human)

Site Information
LPMYRKGtVLIWQKV SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 23114875

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 )
Disease tissue studied:	ovarian cancer ( 1 )
Relevant cell line - cell type - tissue:	KURAMOCHI (ovarian) ( 1 )

References
1	Tucker M (2010) CST Curation Set: 10090; Year: 2010; Biosample/Treatment: cell line, KURAMUCHI/untreated; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991 Curated Info

References

1

Tucker M (2010) CST Curation Set: 10090; Year: 2010; Biosample/Treatment: cell line, KURAMUCHI/untreated; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

Developed with grants from

and literature mining with Linguamatics

PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.